EN HU
logo Tudóstér

Vereb György

Vereb György

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
144
Publications in DEA:
135
OA:
43
Date range:
1990-2024
2024
1.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
Int. J. Mol. Sci. 25 (11), 1-20, (article identifier: 5978), 2024.
doi DEA Scopus
Journal metrics:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
2.
Barden, M., Elsenbroich, P. R., Haas, V., Ertelt, M., Pervan, P., Velas, L., Gergely, B., Szöőr, Á., Harrer, D. C., Bezler, V., Holzinger, A., Friis, R. U. W., Vereb, G., Schütz, G., Schoeder, C. T., Hombach, A. A., Abken, H.: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.
doi DEA WoS Scopus
Journal metrics:
D1 Cancer Research (2023)
D1 Immunology and Allergy (2023)
D1 Immunology (2023)
D1 Molecular Medicine (2023)
D1 Oncology (2023)
D1 Pharmacology (2023)
3.
Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
2023
4.
Barden, M., Holzinger, A., Velas, L., Mezősi-Csaplár, M., Szöőr, Á., Vereb, G., Schütz, G., Hombach, A. A., Abken, H.: CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14, 1-13, (article identifier: 1110482), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
5.
Mezősi-Csaplár, M., Szöőr, Á., Vereb, G.: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
6.
Rebenku, I., Lloyd, C. B., Szöllősi, J., Vereb, G.: Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio.
Sci. Rep. 13 (1), 1-15, (article identifier: 2934), 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Multidisciplinary
7.
Rebenku, I., Bartha, F., Katona, T., Zsebik, B., Antalffy, G., Takács, L., Molnár, B., Vereb, G.: Taking molecular pathology to the next level: whole slide multicolor confocal imaging with the Pannoramic Confocal digital pathology scanner.
Cytom. Part A. 103 (3), 198-207, 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cell Biology
Q1 Histology
Q1 Pathology and Forensic Medicine
2022
8.
Cserepes, M., Nelhűbel, G. A., Meilinger-Dobra, M., Herczeg, A., Türk, D., Hegedűs, Z., Svajda, L., Rásó, E., Ladányi, A., Csikó, K. G., Kenessey, I., Szöőr, Á., Vereb, G., Remenár, É., Tóvári, J.: EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
9.
Blokon-Kogan, D., Levi-Mann, M., Malka-Levy, L., Itzhaki, O., Besser, M. J., Shiftan, Y., Szöőr, Á., Vereb, G., Gross, G., Abken, H., Weinstein-Marom, H.: Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy.
J Immunother Cancer. 10 (9), 1-12, 2022.
doi DEA WoS Scopus
Journal metrics:
D1 Cancer Research
D1 Immunology
D1 Immunology and Allergy
D1 Molecular Medicine
D1 Oncology
D1 Pharmacology
10.
Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M. Á., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Cancer Research
Q1 Immunology
Q1 Immunology and Allergy
D1 Medicine (miscellaneous)
Q1 Oncology
11.
Pócsi, I., Máthéné Szigeti, Z., Emri, T., Boczonádi, I., Vereb, G., Szöllősi, J.: Use of red, far-red, and near-infrared light in imaging of yeasts and filamentous fungi.
Appl. Microbiol. Biotechnol. 106 (11), 3895-3912, 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Applied Microbiology and Biotechnology
Q1 Biotechnology
Q1 Medicine (miscellaneous)
2021
12.
Angyal, Á., Pénzes, Z., Alimohammadi, S., Horváth, D., Takács, L., Vereb, G., Zsebik, B., Bíró, T., Tóth, K. F., Lisztes, E., Tóth, I. B., Oláh, A., Szöllősi, A. G.: Anandamide Concentration-Dependently Modulates Toll-Like Receptor 3 Agonism or UVB-Induced Inflammatory Response of Human Corneal Epithelial Cells.
Int. J. Mol. Sci. 22 (15), 7776, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
13.
Mezősi-Csaplár, M., Szöllősi, J., Gottschalk, S., Vereb, G., Szöőr, Á.: Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
14.
Szöőr, Á., Szöllősi, J., Vereb, G.: From antibodies to living drugs: quo vadis cancer immunotherapy?.
Biol. Futura. 72 (1), 85-99, 2021.
doi DEA
Journal metrics:
Q2 Agricultural and Biological Sciences (miscellaneous)
Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)
15.
Potor, L., Hendrik, Z., Patsalos, A., Katona, É., Méhes, G., Póliska, S., Csősz, É., Kalló, G., Komáromi, I., Combi, Z., Posta, N., Sikura, K. É., Pethő, D., Oros, M., Vereb, G., Tóth, C., Gergely, P., Nagy, L., Balla, G., Balla, J.: Oxidation of hemoglobin drives a proatherogenic polarization of macrophages in human atherosclerosis.
Antioxid. Redox Signal. 35 (12), 917-950, 2021.
doi DEA WoS Scopus
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
D1 Clinical Biochemistry
D1 Medicine (miscellaneous)
Q1 Molecular Biology
D1 Physiology
2020
16.
Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
17.
Volpin, V., Michels, T., Sorrentino, A., Menevse, A. N., Knoll, G., Ditz, M., Milenkovic, V. M., Chen, C. Y., Rathinasamy, A., Griewank, K., Boutros, M., Haferkamp, S., Berneburg, M., Wetzel, C. H., Seckinger, A., Hose, D., Goldschmidt, H., Ehrenschwender, M., Witzens-Harig, M., Szöőr, Á., Vereb, G., Khandelwal, N., Beckhove, P.: CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Cancer Immunol. Res. 8, 1163-1179, 2020.
doi DEA WoS Scopus
Journal metrics:
D1 Cancer Research
D1 Immunology
18.
Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., Vereb, G.: Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484, 1-8, 2020.
doi DEA
Journal metrics:
Q1 Cancer Research
Q1 Oncology
2019
19.
Ujvárosi, A. Z., Riba, M., Garda, T., Gyémánt, G., Vereb, G., Mikóné Hamvas, M., Vasas, G., Máthé, C.: Attack of Microcystis aeruginosa bloom on a Ceratophyllum submersum field: ecotoxicological measurements in real environment with real microcystin exposure.
Sci. Total Environ. 662, 735-745, 2019.
doi DEA WoS Scopus
Journal metrics:
Q1 Environmental Chemistry
D1 Environmental Engineering
D1 Pollution
D1 Waste Management and Disposal
20.
Vámosi, G., Friedländer, E., Ibrahim, S. M., Brock, R., Szöllősi, J., Vereb, G.: EGF Receptor Stalls upon Activation as Evidenced by Complementary Fluorescence Correlation Spectroscopy and Fluorescence Recovery after Photobleaching Measurements.
Int. J. Mol. Sci. 20 (13), 1-22, 2019.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
21.
Trümper, V., von Knethen, A., Preuß, A., Ermilov, E., Hackbarth, S., Kuchler, L., Gunne, S., Schäfer, A., Bornhütter, T., Vereb, G., Ujlaky-Nagy, L., Brüne, B., Röder, B., Schindler, M., Parnham, M. J., Knape, T.: Flow cytometry-based FRET identifies binding intensities in PPAR[gamma]1 protein-protein interactions in living cells.
Theranostics. 9 (19), 5444-5463, 2019.
doi DEA WoS Scopus
Journal metrics:
D1 Medicine (miscellaneous)
D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2018
22.
Barok, M., Puhka, M., Vereb, G., Szöllősi, J., Isola, J., Joensuu, H.: Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation.
BMC Cancer. 18 (1), 504-516, 2018.
doi DEA
Journal metrics:
Q2 Cancer Research
Q2 Genetics
Q1 Oncology
23.
Ujlaky-Nagy, L., Nagy, P., Szöllősi, J., Vereb, G.: Flow cytometric FRET analysis of protein interactions.
In: Flow Cytometry Protocols. Eds.: Teresa S. Hawley, Robert G. Hawley, Springer, New York, 393-419, 2018, (Methods in Molecular Biology, ISSN 1064-3745 ; 1678)
doi DEA
24.
Nagy, M., Kéki, S., Rácz, D., Mathur, J., Vereb, G., Garda, T., Mikóné Hamvas, M., Chaumont, F., Bóka, K., Böddi, B., Freytag, C., Vasas, G., Máthé, C.: Novel fluorochromes label tonoplast in living plant cells and reveal changes in vacuolar organization after treatment with protein phosphatase inhibitors.
Protoplasma. 255 (3), 829-839, 2018.
doi DEA WoS Scopus
Journal metrics:
Q1 Plant Science
Q1 Medicine (miscellaneous)
Q3 Cell Biology
25.
Agod, Z., Pázmándi, K. L., Bencze, D., Vereb, G., Bíró, T., Szabó, A., Rajnavölgyi, É., Bácsi, A., Engel, P., Lányi, Á.: Signaling Lymphocyte Activation Molecule Family 5 Enhances Autophagy and Fine-Tunes Cytokine Response in Monocyte-Derived Dendritic Cells via Stabilization of Interferon Regulatory Factor 8.
Front. Immunol. 9, 1-16, 2018.
doi DEA WoS Scopus
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.